The federal contract indefinite delivery vehicle (IDV) in question is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Puracap Laboratories LLC, doing business as BLU Pharmaceuticals. The contract, identified as 36F79719D0119, is under the Pharmaceuticals and Drugs (FSS-61-IB) schedule and has a ceiling value of $21,231,260. It was awarded on April 1, 2019, with an ultimate completion date of May 31, 2025.
Through this contract, Puracap Laboratories is providing a wide range of pharmaceutical products to support the healthcare requirements of various federal agencies and their beneficiaries, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. These products include commonly prescribed medications such as doxycycline hyclate tablets, simvastatin tablets, and azithromycin suspension. The contract allows for the efficient procurement of these commercial pharmaceuticals through the VA's Pharmaceuticals and Drugs schedule, a proven contracting mechanism designed to meet the ongoing medication needs of federal health programs. By repeatedly awarding contracts to Puracap Laboratories, the VA, Defense Logistics Agency, and Department of Health and Human Services have demonstrated confidence in the company's ability to reliably supply these critical healthcare products.
Generated 2/5/25, 9:05 AM